![](https://www.pdfsearch.io/img/b7659f957c2501b3a830f639925906d0.jpg) Date: 2014-04-14 23:44:58
| | April 16, 2014 Ajinomoto Pharmaceuticals Co., Ltd. Phase 2a Clinical Study Data of AJM300, an Oral 4 Integrin Antagonist, Will Be Presented in Digestive Disease Week 2014Add to Reading ListSource URL: www.ajinomoto-seiyaku.co.jpDownload Document from Source Website File Size: 163,99 KBShare Document on Facebook
|